Imipenem Resistance of Pseudomonas in Nosocomial Pneumonia: A Systematic Literature Review

被引：0
|
作者：
Zilberberg, M. D. [1 ,2 ]
Chen, J. [3 ]
Mody, S. H. [3 ]
Ramsey, A. [2 ]
Shorr, A. F. [4 ]
机构：
[1] Univ Massachusetts, Amherst, MA 01003 USA
[2] EviMed Res Grp LLC, Goshen, MA USA
[3] Ortho McNeil Janssen Sci Affairs LLC, Raritan, NJ USA
[4] Washington Hosp Ctr, Washington, DC 20010 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2009年 / 179卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1587
引用
收藏
页数：1
相关论文
共 50 条
  • [41] RISC FACTORS ASSOCIATED WITH IMIPENEM RESISTANCE IN NOSOCOMIAL ACINETOBACTER BAUMANNII INFECTIONS
    Balci, Mehmet
    Bitirgen, Mehmet
    Kandemir, Bahar
    Aribas, Emel Turk
    Erayman, Ibrahim
    NOBEL MEDICUS, 2012, 8 (03): : 24 - 31
  • [42] Treatment of severe nosocomial pneumonia:: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin
    Torres, A
    Bauer, TT
    León-Gil, C
    Castillo, F
    Alvarez-Lerma, F
    Martínez-Pellús, A
    Leal-Noval, SR
    Nadal, P
    Palomar, M
    Blanquer, J
    Ros, F
    THORAX, 2000, 55 (12) : 1033 - 1039
  • [43] Nosocomial pneumonia and sepsis caused by a rare organism Cedecea lapagei in an infant and a review of literature
    Ramaswamy, Viraraghavan Vadakkencherry
    Gummadapu, Sanghamitra
    Suryanarayana, Nori
    BMJ CASE REPORTS, 2019, 12 (07)
  • [44] Aerosolized colistin in the treatment of multiresistant Pseudomonas aeruginosa nosocomial pneumonia
    Motaouakkil, Said
    Charra, Boubaker
    Hachimi, Abdelhamid
    Benslama, Abdellatif
    SIGNA VITAE, 2009, 4 (02) : 30 - 31
  • [45] Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by Pseudomonas aeruginosa
    Farrington, Nicola
    Dubey, Vineet
    Johnson, Adam
    Horner, Iona
    Stevenson, Adam
    Unsworth, Jennifer
    Jimenez-Valverde, Ana
    Schwartz, Julie
    Das, Shampa
    Hope, William
    Darlow, Christopher A.
    Wright, Gerard D.
    MBIO, 2024, 15 (02):
  • [46] Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes
    Qin Lu
    Philippe Eggimann
    Charles-Edouard Luyt
    Michel Wolff
    Michael Tamm
    Bruno François
    Emmanuelle Mercier
    Jorge Garbino
    Pierre-François Laterre
    Holger Koch
    Verena Gafner
    Michael P Rudolf
    Erkan Mus
    Antonio Perez
    Hedvika Lazar
    Jean Chastre
    Jean-Jacques Rouby
    Critical Care, 18
  • [47] Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes
    Lu, Qin
    Eggimann, Philippe
    Luyt, Charles-Edouard
    Wolff, Michel
    Tamm, Michael
    Francois, Bruno
    Mercier, Emmanuelle
    Garbino, Jorge
    Laterre, Pierre-Francois
    Koch, Holger
    Gafner, Verena
    Rudolf, Michael P.
    Mus, Erkan
    Perez, Antonio
    Lazar, Hedvika
    Chastre, Jean
    Rouby, Jean-Jacques
    CRITICAL CARE, 2014, 18 (01)
  • [48] Carbapenem Antibiotics for the Empiric Treatment of Nosocomial Pneumonia A Systematic Review and Meta-analysis
    Howatt, Mackenzie
    Klompas, Michael
    Kalil, Andre C.
    Metersky, Mark L.
    Muscedere, John
    CHEST, 2021, 159 (03) : 1041 - 1054
  • [49] Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: A systematic review and meta-analysis
    Kalil, Andre C.
    Murthy, Madhu H.
    Hermsen, Elizabeth D.
    Neto, Felipe K.
    Sun, Junfeng
    Rupp, Mark E.
    CRITICAL CARE MEDICINE, 2010, 38 (09) : 1802 - 1808
  • [50] MECHANISM OF IMIPENEM RESISTANCE ACQUIRED BY 3 PSEUDOMONAS-AERUGINOSA STRAINS DURING IMIPENEM THERAPY
    VURMARAPP, U
    KAYSER, FH
    HADORN, K
    WIEDERKEHR, F
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1990, 9 (08) : 580 - 587
12345